Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



King's College London - Health: More than a medical matter






Is cross-border reproductive care a problem, and for whom?

01 September 2009

By Dr Francoise Shenfield

Clinical lecturer in Infertility at UCLH, member of ESHRE's Executive Committee and Taskforce for Law and Ethics; coordinator of ESHRE's Taskforce for Cross-border Reproductive Care

Appeared in BioNews 523
As a clinician based in the UK, one cannot fail to be aware that some patients seek fertility treatments abroad. Until now we only had newspaper headlines or anecdotal evidence, but having presented the results of the first European study in Amsterdam at the annual European Society for Human Reproduction and Embryology (ESHRE) conference (1), we may now base our reflections on some facts, even if selected by the voluntary nature of participating colleagues and centres abroad.

So we know the phenomenon is present and unlikely to disappear, and we may well ask, is it a problem per se? The answer is no, not in the climate of a priori autonomy of our patients in the post modern world, and the fact that the term cross-border care is preferred to 'fertility tourism' is one aspect of the respect we owe our patients who certainly do not travel for fun as a tourist, but out of necessity (2), as most people would much prefer to receive appropriate care on their doorstep. The ethics of cross-border reproductive care have already been discussed by many (3), including our ESHRE Taskforce for ethics and law (4). This is of concern to patients and practitioners alike, let alone regulatory authorities. Knowing the lack of hard facts we decided to start a 'cross-border reproductive care' study in October 2008, thanks to the collaboration of colleagues in six European countries. Patients may feel the need to cross national borders because of their age, marital status (French single women or lesbian couples will seek donor insemination (DI) in Belgium, for example) as well as bans on the technique they need to use (for example PGD  in Germany, gamete donation in Italy). The EU has estimated that one per cent of healthcare spending in any European country is given to citizens from another EU country, and there are plans for 'consumers' to be able to access some care across borders and be reimbursed in their own state, although it may take a long time before this applies to fertility treatments.

But why our patients feel the need to seek care abroad had not been studied systematically. Thus, we started this prospective study, of all foreign women coming from abroad to attend the participating centres for assisted conception: IVF/ICSI, with or without sperm donor; oocyte donation transfer cycles; PGD or PGS (preimplantation genetic screening); embryo donation cycle; insemination with partner's sperm or with donor sperm, for one month, in the six collaborating countries (Belgium, Czech Republic, Denmark, Slovenia, Spain, and Switzerland).

We had two main objectives: to estimate the number of couples who cross borders to obtain infertility treatment and their reasons for doing so and to compare the age distribution of cross-border patients with this of local national patients treated by the same centres.

The results provide the first systematic data available in this field. They are drawn from the analysis of at least 1200 patients' questionnaires, sent by about 50 centres in the six participating countries that volunteered. It should be noted that this merely represents one month's activity, according to the protocol. Whether this information will shame the powers that be into action or support their inaction is yet to be seen, but, there may be some other concerns, mostly regarding safety for our patients and their future offspring. Indeed questions regarding safety (in the case of prospective gametes donors as well as recipient patients) have been asked in the European Parliament. Furthermore, in the UK, we see as expected that patients do not cross borders because of legal reasons - our legislation must be on of the most tolerant in Europe, if not worldwide - but because of difficulties in accessing the services.

Furthermore, what can be learnt from the facts is firstly whether what has merely been surmised until now is in fact evidence-based. Indeed, many Italians escape legal restrictions at hpme by going to Spain for oocyte donation, and to Switzerland for sperm donation. So do French lesbians who go to Belgium for the latter. Legal restrictions are also the cause of the flux of Germans to the Czech Republic, but the British quote access problems as the main reason for their travels. Although aware that the evidence is still partial because of the voluntary nature of the study, it provides a picture of trends, which may inform future policy and gives the cross-border phenomenon 'visibility'.

With my ESHRE hat on, I wish to promote the role of our professional society in informing the law makers, media and the public of the benefits of assisted reproduction technologies for infertile people, point to possibly negative consequences of restrictive legislations and access policies, ensure safety for all concerned (patients and gametes donors), whilst also considering the welfare of the future child. In this respect, the prevention of multiple pregnancy is still an important matter internationally, as indeed this is one of the complications our patients return to us from abroad with.

This very matter was the subject of a study, now published on line for the BJOG (5). This showed that we have seen at University College London Hospital an increase in the numbers of high order multiple pregnancies (triplets, quadruplets and above) in women who have received fertility treatment overseas. The added comment on the website that 'we need international protocols on this urgently, to be agreed by the professionals performing the fertility treatment and those caring for the women' is certainly one ESHRE is in agreement with, and which we will endeavour to put in place for the sake of our patients.


 

SOURCES & REFERENCES
1) Bionews report on the cross-border study presented at ESHRE
|
 
2) Pennings G G. Pennings (2004) Legal harmonization and reproductive tourism in Europe. Hum Reprod 12:2689- 2694
|
 
3) G.Pennings (2006) International parenthood via procreative tourism. In : F.Shenfield and C. Sureau (Eds) Contemporary Ethical Dilemmas in Assisted Reproduction Informa Healthcare, pp 43-56
|
 
4) ESHRE taskforce in Law and Ethics 15, Ethics of Cross- border reproductive care, Human Rep, 2008 23(10):2182-2184
|
 
5) McKelvey A, David A, Shenfield F, Jauniaux E. The impact of cross-border reproductive care or ‘fertility tourism' on NHS maternity services. BJOG 2009
|
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

04 July 2011 - by Rose Palmer 
The shortage of egg and sperm donors, and the cost of IVF in the UK, need to be addressed to reduce the number of people travelling abroad for fertility treatment, according to a report published this week.... [Read More]
29 November 2010 - by Dr Vivienne Raper 
Are European airlines bursting with 'fertility tourists' risking their health by travelling abroad? Do most people seeking fertility treatment overseas fit the media stereotype - white, middle-class career women over 50? Does cross-border reproductive care (CBRC) include eggs imported from abroad? Dr Françoise Shenfield and Professor Lorraine Culley tried to answer these questions during the first session of last Wednesday's Progress Educational Trust (PET) annual conference... [Read More]
05 July 2010 - by Seil Collins 
Expensive UK fertility treatment and long waiting times related to a shortage of egg and sperm donors are the major reasons people seek fertility treatment abroad, according to the first academic study into cross-border reproductive care.... [Read More]
15 March 2010 - by Ailsa Stevens 
A donated human egg will be raffled on Wednesday to mark the launch of a new IVF service which helps UK women to access egg donation services in America. The new service, offered by the Bridge Centre in London, will allow patients to select egg donors on the basis of characteristics such as racial background, health, education and appearance.... [Read More]
11 January 2010 - by Antony Blackburn-Starza 
A British woman has travelled to Denmark to undergo donor insemination after the fertility clinic where she had been receiving treatment in the UK ran out of sperm, BBC News reports. Single and 41, Abby, who is using a pseudonym, made the decision after three unsuccessful insemination attempts in the UK using donated sperm. Once the clinic informed her there was no more sperm available she contacted the Danish clinic. Following treatment there she gave birth to a... [Read More]

18 May 2009 - by Professor Eric Blyth 
What we currently know about cross-border reproductive services derives primarily from anecdotal patient accounts shared on the Internet and reports provided by journalists - often working 'undercover' and posing as patients. The nefarious character of some services under investigation, alleging illegal activities (1,2) and exploitation of young women as egg donors... [Read More]
22 September 2008 - by Sarah Guy 
A report has indicated for the first time the cost faced by the UK's National Health Service (NHS) as it copes with multiple births resulting from IVF patients treated abroad. New research undertaken by the Fetal Medicine Unit at University College London Hospital (UCLH) makes a link... [Read More]
26 August 2008 - by Professor Guido Pennings 
The European Society for Human Reproduction and Embryology (ESHRE) has been concerned about the development of cross-border infertility treatment for some time. There are three reasons for this: the frequently negative publicity for infertility treatment presented as 'reproductive tourism', the increasing numbers and the risks for patients. ESHRE has taken... [Read More]
21 July 2008 - by MacKenna Roberts 
An overwhelming majority of infertility patients in the UK said they would contemplate travelling abroad for fertility treatment, according to the first comprehensive study on the strength and motivations behind the fertility tourism industry. Among the 339 infertile patients who responded to an online poll conducted by... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
RISK ASSESSMENT:
BREAST CANCER, PREDICTION AND SCREENING
FREE public event in central London, 6.30pm on Thursday 8 May 2014 - find out more HERE

ANNIVERSARY APPEAL
Please donate HERE, so that the Progress Educational Trust can continue throughout 2014 (and beyond) while keeping BioNews FREE for you to read

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation